合作類型：技術(shù) 行業(yè)類別: 醫(yī)藥研發(fā) 過期時間：2017年05月25日
一家西班牙專注于細(xì)胞治療研究開發(fā)的生物科技公司開發(fā)了一種適用于移植的軟骨細(xì)胞來治療軟骨損傷，這種細(xì)胞已經(jīng)被證明是修復(fù)軟骨損傷的唯一有效方法。該公司正在尋找制藥公司進(jìn)行下一步的技術(shù)層面研發(fā)工作，他們希望與合作伙伴簽署技術(shù)合作協(xié)議和聯(lián)合經(jīng)營協(xié)議。
英語原文：
Summary:
A Spanish biotechnological company focused on research and development of products for cell therapy, has developed a chondrocyte cell culture for implants to treat cartilage lesions, and has proved to be the only efficient method to cure cartilage lesions. The company is looking for a pharmaceutical company for further development of the cultures on a technical level, through a technical cooperation agreement or joint venture.
Details:
The Spanish biotechnological company´s laboratory has adopted the Good Laboratory Practices (GLP) and Good Manufacture Practices (GMP) certification that allows and facilitates the production of cell cultures. In this case, the chondrocytes produced are used for implant to treat cartilage lesions through the Instant CEMTROCELL technique. This is a technique for cartilage regeneration by means of an implant of autologous cartilage cells (patient's own). It has been shown that this method is the only that cures cartilage lesions and in most cases leads to a total regeneration of the joint surface through the formation of hyaline cartilage.
Although the European legislation allows the usage of this product if it is prescribed by a specialist physicist in a specific hospital after asking for the usage permission, the register of this product in the EMA (European Medicines Agency) will open the international launch of the product.
Therefore the company is looking for technical collaborations in the fields of clinical developments related to cell therapies. The partner sought must carry out the clinical development of the treatment based on the chondrocytes that the Spanish company is producing, as well as proceed after with the drug registration. So it is needed for the partner sought to have large experience and capabilities to support all the technical needs that are required to achieve the project.
The Spanish company is open for technical cooperation and/or for a joint venture agreement.
Type and Role of Partners Sought:
The partner searched should be a pharmaceutical company with enough resources to deal with the clinical development of the chondrocytes, based on the treatment of chondral injury with autologous chondrocytes.
